Long-term prognosis of the jejunal involvement of Crohn's disease

Journal of Clinical Gastroenterology

Volumn 47, Issue 5, 2013, Pages 400-408

  Park, Soo Kyung ^a   Yang, Suk Kyun ^a   Park, Seong Ho ^a   Park, Sang Hyoung ^a   Kim, Jong Wook ^a   Yang, Dong Hoon ^a   Jung, Kee Wook ^a   Kim, Kyung Jo ^a   Ye, Byong Duk ^a   Byeon, Jeong Sik ^a   Myung, Seung Jae ^a   Yu, Chang Sik ^a   Kim, Jin Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Crohn's disease; hospitalization; jejunum; surgery

Indexed keywords

CORTICOSTEROID; MERCAPTOPURINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CHILD; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; HOSPITALIZATION; HUMANS; JEJUNUM; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84876418359     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182705f9e     Document Type: Article

References (49)

1. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465-1470
2. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6-16
3. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123:86-91
4. Yang SK, Park M, Lim J, et al. Contribution of IL23R but not ATG16L1 to Crohn's disease susceptibility in Koreans. Inflamm Bowel Dis. 2009;15:1385-1390
5. Yamazaki K, Onouchi Y, Takazoe M, et al. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet. 2007;52:575-583
6. Yang SK, Lim J, Chang HS, et al. Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol. 2008;103:1437-1442
7. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005;14:3499-3506
8. Tremelling M, Berzuini C, Massey D, et al. Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis. 2008;14: 733-737
9. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study. Inflamm Bowel Dis. 2008;14:542-549
10. Ye BD, Yang SK, Cho YK, et al. Clinical features and longterm prognosis of Crohn's disease in Korea. Scand J Gastroenterol. 2010;45:1178-1185
11. Yang SK, Kim H, Hong M, et al. Association of CARD8 with inflammatory bowel disease in Koreans. J Hum Genet. 2011;56:217-223
12. Hanauer SB. Crohn's disease: Step up or top down therapy. Best Pract Res Clin Gastroenterol. 2003;17:131-137
13. Lemann M, Mary JY, Duclos B, et al. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: A randomized placebo-controlled trial. Gastroenterology. 2006;130:1054-1061
14. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: An open randomised trial. Lancet. 2008;371:660-667
15. D'Haens GR. Top-down therapy for IBD: Rationale and requisite evidence. Nat Rev Gastroenterol Hepatol. 2010;7: 86-92
16. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006;130:650-656
17. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010;139:1147-1155
18. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36
19. Wolters FL, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut. 2006;55:1124-1130
20. Chow DK, Sung JJ, Wu JC, et al. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm Bowel Dis. 2009;15: 551-557
21. Cosnes J, Cattan S, Blain A, et al. Long-Term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250
22. Freeman HJ. Long-Term clinical behavior of jejunoileal involvement in Crohn's disease. Can J Gastroenterol. 2005;19:575-578
23. Higuero T, Merle C, Thiefin G, et al. Jejunoileal Crohn's disease: A case-control study. Gastroenterol Clin Biol. 2004;28: 160-166
24. Tan WC, Allan RN. Diffuse jejunoileitis of Crohn's disease. Gut. 1993;34:1374-1378
25. Keh C, Shatari T, Yamamoto T, et al. Jejunal Crohn's disease is associated with a higher postoperative recurrence rate than ileocaecal Crohn's disease. Colorectal Dis. 2005;7:366-368
26. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19
27. Goldstein JL, Eisen GM, Lewis B, et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133-141
28. Seksik P, Loftus EV Jr, Beaugerie L, et al. Validation of predictors of 5-year disabling CD in a population based cohort from Olmsted County, Minnesota, 1983-1996. Gastroenterology. 2007;132(suppl):A17
29. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis. 2010;4:7-27
30. Loly C, Belaiche J, Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol. 2008;43:948-954
31. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000;231:38-45
32. Solberg IC, Vatn MH, Høie O, et al. Clinical course in Crohn's disease: Results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5: 1430-1438
33. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: A population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481-489
34. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis. 2010;4:28-62
35. Hwangbo Y, Kim HJ, Park JS, et al. Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement. Gut Liver. 2010;4:338-344
36. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646-651
37. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995-1000
38. D'Inca R, Sturniolo G, Cassaro M, et al. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease. Dig Dis Sci. 1998;43:988-992
39. Alcantara M, Rodriguez R, Potenciano JL, et al. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease. Endoscopy. 1993;25: 282-286
40. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics. 1989;83:777-781
41. Korelitz BI, Waye JD, Kreuning J, et al. Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum. Am J Gastroenterol. 1981;76:103-109
42. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: A prospective study. J Gastroenterol Hepatol. 1991;6:355-358
43. Lazarev M, Hutfless S, Bitton A, et al. 760 divergence in L4 Crohn's disease: Jejunal, not esophagogastroduodenal Involvement, is protective of L2 disease location, and a risk for stricturing behavior and multiple abdominal surgeries. Report from the NIDDK-IBDGC registry. Gastroenterology. 2010; 138:S-105
44. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis. 2011;17: 1314-1321
45. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-Analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease. Am J Gastroenterol. 2006;101:954-964
46. Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: Preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-Through, and ileoscopy. Radiology. 2006;238:128-134
47. Wold PB, Fletcher JG, Johnson CD, et al. Assessment of small bowel Crohn disease: Noninvasive peroral CT enterography compared with other imaging methods and endoscopy-feasibility study. Radiology. 2003;229:275-281
48. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: Comparison of CT enterography, MR enterography, and small-bowel follow-Through as diagnostic techniques. Radiology. 2009;251:751-761
49. Solem CA, Loftus EV, Fletcher JG, et al. Small-bowel imaging in Crohn's disease: A prospective, blinded, 4-way comparison trial. Gastrointest Endosc. 2008;68:255-266